D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.07B
| $2.07M | ﹤0.01% |
20,382
+17,683
| +655% | +$1.72M |
|
2477
Mizuho Financial
MFG
$132B
| $2.06M | ﹤0.01% |
518,268
+388,457
| +299% | +$1.45M |
|
2478
Ouster
OUST
$2.48B
| $2.06M | ﹤0.01% |
259,413
+109,397
| +73% | +$623K |
|
2479
Janux Therapeutics
JANX
$1.01B
| $2.06M | ﹤0.01% |
+54,638
| New | +$1.19M |
|
|
SGMO
2480
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.06M | ﹤0.01% |
3,067,435
-1,616,538
| -35% | -$1.17M |
|
2481
MBIA
MBI
$225M
| $2.05M | ﹤0.01% |
303,851
+118,603
| +64% | +$750K |
|
2482
AbCellera Biologics
ABCL
$4.06B
| $2.05M | ﹤0.01% |
453,235
+422,602
| +1,380% | +$2.16M |
|
2483
Lantheus
LNTH
$6.58B
| $2.04M | ﹤0.01% |
32,850
-10,612
| -24% | -$624K |
|
2484
Blue Bird Corp
BLBD
$1.92B
| $2.04M | ﹤0.01% |
53,219
+9,743
| +22% | +$298K |
|
2485
CALL
TKO Group
TKO
$13.9B
| $2.04M | ﹤0.01% |
23,600
-14,600
| -38% | -$1.22M |
|
2486
PUT
H&R Block
HRB
$5.44B
| $2.04M | ﹤0.01% |
41,500
-20,700
| -33% | -$983K |
|
2487
CALL
Advance Auto Parts
AAP
$2.55B
| $2.03M | ﹤0.01% |
23,900
+9,200
| +63% | +$635K |
|
|
GOOS
2488
Canada Goose Holdings
GOOS
$728M
| $2.02M | ﹤0.01% |
167,710
+137,448
| +454% | +$1.71M |
|
2489
InterContinental Hotels
IHG
$22.3B
| $2.02M | ﹤0.01% |
19,126
-17,853
| -48% | -$1.79M |
|
2490
Arcosa
ACA
$7.15B
| $2.02M | ﹤0.01% |
23,527
-28,505
| -55% | -$2.32M |
|
2491
Cimpress
CMPR
$1.94B
| $2.02M | ﹤0.01% |
22,814
+836
| +4% | +$70.9K |
|
2492
PUT
Nabors Industries
NBR
$1.29B
| $2.02M | ﹤0.01% |
23,400
-10,000
| -30% | -$818K |
|
|
DOOR
2493
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.01M | ﹤0.01% |
15,298
-50,442
| -77% | -$5.68M |
|
2494
CTS Corp
CTS
$1.64B
| $2.01M | ﹤0.01% |
42,946
-9,330
| -18% | -$409K |
|
|
MIR.WS
2495
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
| $2.01M | ﹤0.01% |
895,357
| – | – |
|
|
ENV
2496
DELISTED
ENVESTNET, INC.
ENV
| $2M | ﹤0.01% |
34,546
-11,239
| -25% | -$586K |
|
2497
Caleres
CAL
$405M
| $2M | ﹤0.01% |
48,671
-15,650
| -24% | -$547K |
|
2498
Hyatt Hotels
H
$14.6B
| $1.99M | ﹤0.01% |
12,473
-75,663
| -86% | -$10.7M |
|
2499
iShares MSCI India ETF
INDA
$6.51B
| $1.99M | ﹤0.01% |
38,543
+18,297
| +90% | +$923K |
|
|
CCRN
2500
DELISTED
Cross Country Healthcare
CCRN
| $1.99M | ﹤0.01% |
106,212
+41,409
| +64% | +$828K |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.